Regen BioPharma Inc (RGBP)

[Fitzgerald]

The following article appeared on 12/17/15 in Investor Wired:

Molycorp Inc (OTCMKTS:MCPIQ) was trading lower by -16.39% to $0.0250.So far, around 322,455 shares have changed hands in this session. After opening at $0.03, the stock hit as high as $0.03. However, it traded between $0.02 and $1.15 over the last twelve months. Molycorp Inc (OTCMKTS:MCPIQ) a development stage company, through its subsidiary, Regen BioPharma, Inc., intends to engage primarily in the development of regenerative medical applications. It develops HemaXellerate I, which is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies. The company is based in La Mesa, California.

Has BMSN Found The Bottom and Ready To Move Up? Find Out Here

Bio Matrix Scientific Group Inc (OTCMKTS:BMSN) was at $0.00020, showing a -33.33% decrease. Around 56.55 million shares have been traded, versus an-average trading volume of 26.33 million shares. Bio Matrix Scientific Group Inc (OTCMKTS:BMSN) produces and sells rare earths and rare metal materials in the United States and internationally. The company’s Resources segment extracts rare earth minerals, including light rare earth concentrates; rare earth oxides (REO), such as lanthanum, cerium, and neodymium-praseodymium; heavy rare earth concentrates, which include europium, gadolinium, terbium, dysprosium, and others; and SorbX and PhosFIX, a line of rare earth-based water treatment products. This segments products are used in oil refinery catalyst, automotive and emission catalysts, water purification, and energy efficiency lighting applications.